AstraZeneca: Consistent Growth And Upcoming Catalysts Make This A Buy (NASDAQ:AZN)

Core Insights - AstraZeneca PLC, based in Cambridge, UK, was established in 1999 through the merger of Zeneca Group and Astra AB, with its primary listing in the UK [1] Company Overview - AstraZeneca is a major player in the pharmaceutical industry, focusing on developing innovative medicines [1] Investment Philosophy - The approach to investing emphasizes the importance of compounding, dividend reinvesting, and patient investing through various market conditions [1] - The strategy includes a mix of steady accumulation of high-quality assets along with high-risk, high-reward opportunities and transformative technologies [1]